LGALS3 and glioblastoma: Whereas Gal-3 reduced Wnt signaling in the SVZ it increases it in pancreatic, breast, colon and tongue cancers [27,70,71,72], as well as in glioblastoma cell-lines (Al-Dalahmah, O–unpublished).